China Jo-Jo Drugstores, Inc. (CJJD) Financials

$2.22

north_east
$0.42 (23.33%)
Day's range
$1.79
Day's range
$2.26

CJJD Income statement / Annual

Last year (2024), China Jo-Jo Drugstores, Inc.'s total revenue was $154.54 M, an increase of 3.85% from the previous year. In 2024, China Jo-Jo Drugstores, Inc.'s net income was -$4.23 M. See China Jo-Jo Drugstores, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2024 FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015
Period Ended 03/31/2024 03/31/2023 03/31/2022 03/31/2021 03/31/2020 03/31/2019 03/31/2018 03/31/2017 03/31/2016 03/31/2015
Operating Revenue $154.54 M $148.81 M $164.39 M $133.13 M $117.33 M $107.55 M $96.11 M $81.50 M $89.07 M $76.90 M
Cost of Revenue $123.43 M $114.53 M $127.87 M $103.89 M $91.80 M $82.44 M $75.99 M $64.87 M $71.55 M $64.46 M
Gross Profit $31.11 M $34.28 M $36.52 M $29.24 M $25.53 M $25.11 M $20.13 M $16.63 M $17.51 M $12.44 M
Gross Profit Ratio 0.2 0.23 0.22 0.22 0.22 0.23 0.21 0.2 0.2 0.16
Research and Development Expenses $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
General & Administrative Expenses $7.26 M $15.67 M $8.19 M $10.90 M $8.11 M $1.72 M $17.82 M $7.68 M $5.18 M $313,390.00
Selling & Marketing Expenses $27.39 M $29.18 M $30.88 M $26.95 M $23.79 M $24.27 M $18.74 M $12.92 M $12.36 M $10.42 M
Selling, General & Administrative Expenses $34.64 M $44.85 M $39.06 M $37.85 M $31.90 M $25.98 M $36.56 M $20.61 M $17.54 M $10.73 M
Other Expenses $0.00 $1.68 M $455,547.00 $176,519.00 -$204,064.00 -$93,311.00 $201,096.00 $19,888.00 -$43,535.00 $295,018.00
Operating Expenses $34.64 M $44.85 M $39.06 M $37.85 M $31.90 M $25.98 M $36.56 M $20.61 M $17.54 M $10.73 M
Cost And Expenses $158.08 M $159.38 M $166.94 M $141.74 M $123.70 M $108.43 M $112.55 M $85.48 M $89.09 M $75.19 M
Interest Income $516,637.00 $883,908.00 $401,921.00 $707,878.00 $1.06 M $112,887.00 $478,976.00 $379,790.00 $299,511.00 $0.00
Interest Expense $13,604.00 $65,854.00 $262,218.00 $455,187.00 $698,518.00 $241,837.00 $1.23 M $1,349.00 $155,578.00 $1.88 M
Depreciation & Amortization $5.38 M $718,002.00 $1.26 M $1.81 M $2.08 M $1.45 M $1.38 M $1.32 M $1.46 M $2.82 M
EBITDA $1.23 M -$19.96 M -$579,928.00 -$6.08 M -$3.66 M $266,561.00 -$15.05 M -$4.24 M $2.00 M $4.53 M
EBITDA Ratio 0.01 -0.05 -0 -0.04 -0.03 0.01 -0.15 -0.03 0.01 0.07
Operating Income Ratio -0.02 -0.07 -0.02 -0.06 -0.05 -0.01 -0.17 -0.05 -0 0.02
Total Other Income/Expenses Net -$636,817.00 $181,147.00 $446,455.00 $264,794.00 -$65,869.00 -$306,876.00 -$545,693.00 -$1.58 M $568,663.00 -$795,158.00
Income Before Tax -$4.17 M -$20.74 M -$2.10 M -$8.34 M -$6.44 M -$1.18 M -$16.98 M -$5.56 M $543,897.00 $913,026.00
Income Before Tax Ratio -0.03 -0.14 -0.01 -0.06 -0.05 -0.01 -0.18 -0.07 0.01 0.01
Income Tax Expense $62,862.00 $394,541.00 $1.10 M $31,638.00 $16,258.00 $134,763.00 $76,256.00 $84,387.00 $96,741.00 $57,398.00
Net Income -$4.23 M -$21.14 M -$3.20 M -$8.38 M -$6.46 M -$1.32 M -$17.06 M -$5.64 M $447,156.00 $856,557.00
Net Income Ratio -0.03 -0.14 -0.02 -0.06 -0.06 -0.01 -0.18 -0.07 0.01 0.01
EPS -2.93 -41.46 -220.62 -49.29 -47.23 -0.55 -8.16 -3.36 0.36 0.72
EPS Diluted -2.93 -41.46 -220.62 -49.29 -47.23 -0.55 -8.11 -3.32 0.36 0.72
Weighted Average Shares Out $1.44 M $509,827.00 $14,497.00 $169,919.00 $136,735.00 $2.41 M $2.09 M $1.68 M $1.34 M $1.25 M
Weighted Average Shares Out Diluted $1.44 M $509,827.00 $14,497.00 $169,919.00 $136,735.00 $2.41 M $2.10 M $1.70 M $1.35 M $1.26 M
Link